journal article·2021-01-13

Highly Efficient Photothermal Therapy with Cell-Penetrating Peptide-Modified Bumpy Au Triangular Nanoprisms using Low Laser Power and Low Probe Dose

Minji Ha, So Hee Nam, Kyunjong Sim, Seung-Eun Chong, Jiyeon Kim, Yuna Kim, Yan Lee, Jwa-Min Nam

Nano Letters· Volume 21· Issue 1
Publisher page

Abstract

Photothermal therapy (PTT) exploits nanomaterials with optimal heat conversion and cellular penetration using near-infrared (NIR) laser irradiation. However, current PTT agents suffer from inefficient heat conversion, poor intracellular delivery, and a high dose of probes along with excessive laser irradiation, causing limited therapeutic outcomes. Here, bumpy Au triangular nanoprisms (BATrisms) are developed for increasing the surface area, improving cell penetration, shifting the absorption peak to the NIR region, and enhancing the photothermal conversion efficiency (∼86%). Further, leucine (L)- and lysine (K)-rich cell-penetrating peptides (LK peptides) were employed to largely improve their cellular uptake efficiency. Importantly, a significant in vivo therapeutic efficacy with LK-BATrisms was demonstrated in a triple-negative breast cancer xenograft mice model. A very small dose of LK-BATrism (2.5 μg Au) was enough to exert antitumor efficacy under very low laser power (808 nm, 0.25 W/cm 2 ), causing minimal tissue damages while very efficiently killing cancer cells.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Extracellular vesicles in disease · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemistry, Seoul National University, Seoul 08826, South Korea

Funding

National Research Foundation of Korea · Ministry of Science and ICT of Korea

References (51)

Show source-provided references
1. 10.1021/acs.langmuir.9b0300110.1021/acs.langmuir.9b03001 ↗
2. 10.1038/srep1170910.1038/srep11709 ↗
3. 10.1002/adfm.20150200310.1002/adfm.201502003 ↗
4. 10.1021/acsnano.7b0687010.1021/acsnano.7b06870 ↗
5. 10.1002/anie.20200300410.1002/anie.202003004 ↗
6. 10.1021/acs.accounts.9b0056910.1021/acs.accounts.9b00569 ↗
7. 10.1016/j.biomaterials.2014.07.06410.1016/j.biomaterials.2014.07.064 ↗
8. 10.1016/j.biomaterials.2019.11970010.1016/j.biomaterials.2019.119700 ↗
9. 10.1021/cr400532z10.1021/cr400532z ↗
10. 10.1021/acs.chemrev.8b0073810.1021/acs.chemrev.8b00738 ↗
11. 10.1002/advs.20190047110.1002/advs.201900471 ↗
12. 10.1021/acs.bioconjchem.0c0013510.1021/acs.bioconjchem.0c00135 ↗
13. 10.1021/ja304180y10.1021/ja304180y ↗
14. 10.1021/acs.chemrev.7b0019410.1021/acs.chemrev.7b00194 ↗
15. 10.1021/acsami.7b0301710.1021/acsami.7b03017 ↗
16. 10.1021/acs.chemrev.9b0023410.1021/acs.chemrev.9b00234 ↗
17. 10.1039/C5RA17385J10.1039/C5RA17385J ↗
18. 10.1021/nn505468v10.1021/nn505468v ↗
19. 10.1039/C7RA01101F10.1039/C7RA01101F ↗
20. 10.1002/smll.20160028910.1002/smll.201600289 ↗
21. 10.7150/thno.2054510.7150/thno.20545 ↗
22. 10.1021/ja508569910.1021/ja5085699 ↗
23. 10.1021/acs.langmuir.6b0206410.1021/acs.langmuir.6b02064 ↗
24. 10.1002/anie.20140468410.1002/anie.201404684 ↗
25. 10.1039/C8SC00074C10.1039/C8SC00074C ↗
26. 10.1002/advs.20180024010.1002/advs.201800240 ↗
27. 10.1016/j.jconrel.2019.11.03410.1016/j.jconrel.2019.11.034 ↗
28. 10.1021/jacs.9b1051010.1021/jacs.9b10510 ↗
29. 10.1021/cm302039710.1021/cm3020397 ↗
30. 10.1021/nl504126u10.1021/nl504126u ↗
31. 10.1039/C5TC03389F10.1039/C5TC03389F ↗
32. 10.1021/ja305245g10.1021/ja305245g ↗
33. 10.1039/C6RA11405A10.1039/C6RA11405A ↗
34. 10.1021/nn103047r10.1021/nn103047r ↗
35. 10.1021/acsami.5b0085810.1021/acsami.5b00858 ↗
36. 10.1021/acsnano.5b0717210.1021/acsnano.5b07172 ↗
37. 10.1021/acsnano.8b0412810.1021/acsnano.8b04128 ↗
38. 10.1021/acsnano.9b0538310.1021/acsnano.9b05383 ↗
39. 10.1021/acsabm.9b0052110.1021/acsabm.9b00521 ↗
40. 10.1021/acsnano.5b0387610.1021/acsnano.5b03876 ↗
41. 10.1021/ja211035w10.1021/ja211035w ↗
42. 10.1021/ja311180x10.1021/ja311180x ↗
43. 10.1021/acs.molpharmaceut.6b0000410.1021/acs.molpharmaceut.6b00004 ↗
44. 10.1139/y04-11310.1139/y04-113 ↗
45. 10.1021/acsnano.8b0605810.1021/acsnano.8b06058 ↗
46. 10.1021/acsnano.8b0955210.1021/acsnano.8b09552 ↗
47. 10.1158/0008-5472.CAN-06-382210.1158/0008-5472.CAN-06-3822 ↗
48. 10.1021/acsbiomaterials.7b0020710.1021/acsbiomaterials.7b00207 ↗
49. 10.1002/smll.20160258010.1002/smll.201602580 ↗
50. 10.1016/j.biomaterials.2017.12.00310.1016/j.biomaterials.2017.12.003 ↗
51. 10.1039/C9TB01503E10.1039/C9TB01503E ↗